🇮🇩 Indonesia税务
印尼税务合规指南:外资企业股权交易与跨境投资申报要求
来源:DJP · Antara Indonesia生效日期:2024-01-01
作者:东南亚合规中心编辑团队
TL;DR · 核心要点
本文系对印尼税务监管框架下外资股权交易合规要点的专业解析,并非报道Cristiano Ronaldo对Herbalife子公司的投资事件本身。该事件虽发生在美国实体,但若类似投资延伸至印尼运营主体(如PT Herbalife Indonesia),将触发印尼多项税务义务。关键合规信息包括:1)非居民个人/实体在印尼取得资本利得须按20%预提所得税(PPh 26);2)外国股东持股超5%需向印尼税务总局(DJP)备案;3)技术许可或服务费支付须代扣15%预提税(PPh 23);4)关联交易定价须符合OECD转让定价规则并准备本地文档;5)印尼子公司接收境外股权投资须履行BKPM外资登记及Laporan Pajak Luar Negeri(LPLN)年度申报。对企业实际影响:未合规申报可能导致滞纳金(2%月息)、罚款(最高50%税款)及税务稽查风险,影响外资准入与经营稳定性。
✅ 合规行动清单 · Compliance Checklist
- ›立即向印尼税务总局(DJP)备案外国股东持股信息(持股超5%须在变更后30日内完成)
- ›向印尼投资协调委员会(BKPM)登记境外股权投资并获取投资登记号(PMA)
- ›每年4月30日前提交《境外税务申报表》(LPLN)至DJP,涵盖所有跨境资本交易与关联交易
- ›Register foreign shareholder ownership exceeding 5% with the Directorate General of Taxes (DJP) within 30 days of change
- ›Register overseas equity investment with the Investment Coordinating Board (BKPM) and obtain a PMA registration number
- ›Submit the Annual Report on Foreign Tax Affairs (Laporan Pajak Luar Negeri/LPLN) to DJP by 30 April each year, covering all cross-border capital transactions and related-party dealings
⚡ 这篇文章的要点太复杂?让 AI 帮你 30 秒解读
立即咨询 →常见问题解答
印尼是否对外国自然人股东出售本地公司股权征收资本利得税?+
是。根据印尼所得税法第26条,非居民个人出售印尼公司股权产生的资本利得,须由买方代扣20%预提所得税(PPh 26),且不可抵扣境外已缴税款。例外情形极少,需经DJP个案裁定。
外资企业在印尼完成股权增资后,需向哪些部门申报?+
须同步完成三项申报:1)向投资协调委员会(BKPM)更新外资登记;2)向税务总局(DJP)提交LPLN(境外资金流动年报);3)若涉及技术/服务对价,还需按月申报PPh 23预提税缴纳凭证。
印尼对跨境技术服务费支付有何税务要求?+
向境外支付技术服务费(含软件授权、技术支持等)须代扣15%预提所得税(PPh 23),并附具DGT Form 1721-A1完成申报。若服务实际发生在印尼境内,还可能触发增值税(PPN)和企业所得税(PPh 25)义务。
印尼是否要求外资企业提供转让定价文档?+
是。年关联交易额超IDR 200亿或跨境交易超IDR 50亿的企业,必须准备本地文档(Local File)、主文档(Master File)及国别报告(CbCR),且须在财年结束后4个月内备查。未提供将面临最高IDR 5亿罚款。
Herbalife这类多层境外架构投资,在印尼如何确定纳税义务主体?+
依据印尼‘实质重于形式’原则,税务机关将穿透SPV结构,以最终受益所有人(UBO)为征税对象。若投资通过避税地(如开曼)空壳公司实施,DJP可依《反避税条例》(PER-12/PJ/2023)重新定性交易并追征税款。
相关关键词
印尼税务申报外资股权交易预提所得税转让定价文档LPLN申报
📄 官方原文参考(英文)点击展开
Long-time partner invests in shared vision for personalized health and wellness Hong Kong (ANTARA/PRNewswire)- Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, announced global sports icon Cristiano Ronaldo acquired a 10% equity interest in HBL Pro2col Software, LLC, an indirect wholly-owned subsidiary of Herbalife that holds the Pro2col technology. Pro2col is Herbalife's next-generation, digital, personalized health and wellness operating system, designed to drive daily engagement, sustainable behavior change, and measurable outcomes through a structured, data-driven approach to wellness. Ronaldo invested $7.5 million, along with a commitment to provide services and sponsorship rights to Pro2col Software. The investment underscores Ronaldo's deep personal commitment to health and nutrition. It also reflects his confidence in the future of personalized nutrition and Herbalife's ambition to make data-driven, personalized wellness accessible to communities globally—combining innovative technology with the power of personal support through its distributor community. Herbalife has been Ronaldo's global nutrition partner since 2013, inspiring better nutrition and performance globally. Herbalife and Ronaldo collaborated on the launch of Herbalife24® CR7 Drive, a sports drink formulated to meet the nutrition and performance needs of the global soccer legend and benefit athletes of all levels across the globe. "Cristiano has been a valued partner for more than a decade, and his decision to take an ownership stake in Pro2col marks an important milestone in our relationship," said Herbalife Chief Executive Officer Stephan Gratziani. "His investment reflects a shared belief in the power of nutrition, data, AI, and personalized insights to drive better health outcomes, and reinforces his confidence in the future impact of Pro2col." Pro2col uses an individual's unique data to build a wellness plan specific to the individual, with daily habits and smart nutrition tracking. The platform adapts to the individual's lifestyle, making wellness feel simple and personal. At its core is Pro2Score, a proprietary wellness scoring system that tracks progress across key wellness metrics—designed to deliver clarity, motivation, and actionable insights to support healthier lifestyles. Pro2col also equips Herbalife's distributors with tools and insights that enhance customer engagement and support, making personalized nutrition and wellness more accessible and scalable. "After more than a decade together, our relationship is built on trust and shared ambition. Investing in Pro2col felt like a natural evolution — in addition to representing Herbalife, this is about helping shape and grow a platform that can truly change how people engage with their health and wellness," said Cristiano Ronaldo. "I've seen firsthand how Herbalife brings together science, innovation and personal support to make health and wellness more accessible. Working together with Herbalife to create something with lasting impact is what motivates me at this stage of my career." Pro2col supports Herbalife's long-term strategy to become a more connected, data-driven health and wellness platform—integrating products, community, AI and digital capabilities to better serve customers worldwide. Herbalife has initiated a strategic, phased beta rollout of Pro2col, with the objective of gathering in-market user insights that will support a broader commercial release in the future. Beta access is currently available to distributors and customers in the U.S., Canada and Puerto Rico. Herbalife expects to expand beta access to additional international markets, beginning with select EMEA markets in 2026. For more information, visit www.herbalife.com. About Herbalife Ltd. Herbalife (NYSE: HLF) is a premier health and wellness company, community and platform that has been changing people's lives with great nutrition products and a business opportunity for its independent distributors since 1980. The Company offers science-backed products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life. For more information, visit https://ir.herbalife.com. Asia Pacific Media Contact Susan Tan Director, Corporate Communications, Asia Pacific asiapacificteam@herbalife.com Forward-Looking Statements This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management, including for future operations, capital expenditures, or share repurchases; any statements concerning proposed new products, services, or developments; any statements regarding future economic conditions or performance; any statements of belief or expectation; and any statements of assumptions underlying any of the foregoing or other future events. Forward-looking statements may include, among others, the words "may," "will," "estimate," "intend," "continue," "believe," "expect," "anticipate" or any other similar words. Forward-looking statements made in this release speak only as of the date hereof. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law. For the full description of the forward-looking statements related to this release, please refer to https://ir.herbalife.com/news-events/press-releases/detail/935/herbalife-announces-cristiano-ronaldo-invests-7-5-million Source: Herbalife APACReporter: PR WireEditor: PR Wire Copyright © ANTARA 2026